Setting Sail with Data and AI, Charting a Shared Vision for Health: Weiming Penguin and Jingfukang Pharmaceutical Group Deepen Their Strategic Partnership
Article images may contain Chinese text.
In July, Chengde’s misty waters, fragrant islets, and serene imperial grounds were graced by a refreshing breeze. Led by co-founder and President Tian Ying, the Weiming Penguin team was invited to visit Jingfukang Pharmaceutical Group, a leading pharmaceutical company in Chengde. General Manager Wang Yichao and his team warmly welcomed the visitors!
The two companies have worked together for many years. On this visit to Jingfukang Pharmaceutical Group, Weiming Penguin aimed both to review project achievements and to look ahead. We are grateful for the Jingfukang team’s trust and support; through sincere cooperation, both sides are looking toward further successes. They also discussed how Weiming Penguin’s latest AI technologies and DIG digital intelligence solution portfolio could provide more efficient, precise services for Jingfukang Pharmaceutical’s new digital intelligence journey and help improve the group’s operational efficiency.

Founded in 1952, Jingfukang Pharmaceutical Group Co., Ltd. is a large enterprise group that combines manufacturing and commerce, integrating the cultivation and breeding of traditional Chinese medicinal resources, traditional Chinese medicine manufacturing, pharmaceutical trade and distribution, and traditional Chinese medicine research and development. It is among China’s top 50 traditional Chinese medicine enterprises, one of Hebei Province’s leading pharmaceutical manufacturers, and a Key High-Tech Enterprise under China’s National Torch Program.
As a well-known pharmaceutical company in China, Jingfukang Pharmaceutical has long been committed to improving the standards and quality of pharmaceutical services while continuously advancing its digital transformation and upgrades. This deeper collaboration with Weiming Penguin is an important step that reflects its recognition of the inevitable trend toward digital intelligence in the pharmaceutical industry and its active pursuit of technological innovation to optimize supply chain management and enhance its overall competitiveness.

This collaboration is not only part of both companies’ strategic planning for their own sustainable development, but also a new starting point and a new level for their shared future growth. The further deepening of the partnership between Weiming Penguin and Jingfukang Pharmaceutical underscores their shared vision of “connecting life and health.” Going forward, both sides will continue to pursue mutually beneficial cooperation, deepen their partnership, fully leverage their respective strengths, improve product R&D capabilities and market competitiveness, and help the industry develop with higher quality and greater sustainability.

Weiming Penguin’s DIG digital intelligence solutions have brought a data revolution to the pharmaceutical industry. With the robust support of DIG and practical applications of AI and other technologies, pharmaceutical companies can achieve data-driven growth and sustainable development. This is the mission of DIG digital intelligence solutions and a continuing driving force behind Weiming Penguin’s future development.
In looking back on this visit and partnership, we have not only witnessed the strong foundation of cooperation between the two companies but also looked ahead to a digital journey filled with possibilities. We sincerely wish the Jingfukang Pharmaceutical Group and Weiming Penguin teams every success as they move forward together, navigate the wave of digital intelligence in the pharmaceutical industry, and achieve outstanding results. May our partnership be as clear and far-reaching as Chengde’s blue waters and skies, as we write a new chapter for the healthcare industry together, benefiting the public and building a healthier future.